Yulanda Miller Email

Associate Director, Payroll & Equity Compensation . Pear Therapeutics

Current Roles

Employees:
60
Revenue:
$7.3M
About
At Pear, our mission is clear: we are pioneers in Prescription Digital Therapeutics, or PDTs. Our cross-functional team operates at the intersection of biotechnology and software technology. Pear discovers, develops, and delivers clinically-validated software-based therapeutics to provide better outcomes for patients, smarter engagement and tracking tools for clinicians, and cost-effective solutions for payers. Every day, we push the boundaries of technology to transform medicine. Pear has a pipeline of products and product candidates across therapeutic areas, including mental health disorders, severe insomnia and multiple sclerosis. Our lead product, reSET®, treats Substance Use Disorder, and was the first PDT to receive marketing authorization from the FDA to treat disease. Pear's second product candidate, reSET-O for the treatment of Opioid Use Disorder, is currently under review by the FDA with Breakthrough Designation. For more information, visit us at www.peartherapeutics.com.
Pear Therapeutics Address
200 State St
Boston, MA
United States
Pear Therapeutics Email

Past Companies

ICO Energy and Engineering, Inc.Director, Business Operations and Payroll
Pear TherapeuticsAssociate Director, Payroll & Equity Compensation
Turbonomic, an IBM companyDirector, Global Payroll

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.